Lead Optimization: TRPV6-Targeted Radioligand Therapy & SAR Analysis for Optimal Ligand Decision Making
- Characterization of a novel target that expressed in several solid tumors
- Structure Activity Relationship (SAR) analysis in choosing best ligand to take into a Phase 0 clinical trial